The metabolic reprogramming and vulnerability of SF3B1 mutations

被引:4
|
作者
Dalton, W. Brian [1 ]
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, 1650 Orleans St,CRBI Room 285, Baltimore, MD 21231 USA
关键词
spliceosome; serine; PHGDH; metabolism;
D O I
10.1080/23723556.2019.1697619
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in the splicing factor 3b subunit 1 (SF3B1) gene create a neomorphic protein that disrupts RNA splicing, but the downstream consequences of this missplicing are unclear. Our recent study of isogenic human cells demonstrated that SF3B1(MUT) induces reprogramming of energy metabolism and a targetable vulnerability to deprivation of the nonessential amino acid serine.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation
    Dalton, W. Brian
    Helmenstine, Eric
    Walsh, Noel
    Gondek, Lukasz P.
    Kelkar, Dhanashree S.
    Read, Abigail
    Natrajan, Rachael
    Christenson, Eric S.
    Roman, Barbara
    Das, Samarjit
    Zhao, Liang
    Leone, Robert D.
    Shinn, Daniel
    Groginski, Taylor
    Madugundu, Anil K.
    Patil, Arun
    Zabransky, Daniel J.
    Medford, Arielle
    Lee, Justin
    Cole, Alex J.
    Rosen, Marc
    Thakar, Maya
    Ambinder, Alexander
    Donaldson, Joshua
    DeZern, Amy E.
    Cravero, Karen
    Chu, David
    Madero-Marroquin, Rafael
    Pandey, Akhilesh
    Hurley, Paula J.
    Lauring, Josh
    Park, Ben Ho
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (11): : 4708 - 4723
  • [2] SF3B1 Mutations in Hematological Malignancies
    Cilloni, Daniela
    Itri, Federico
    Bonuomo, Valentina
    Petiti, Jessica
    CANCERS, 2022, 14 (19)
  • [3] SF3B1 mutations induce proteome remodeling, metabolic reprogramming, and a novel kind of tumor surface antigen in human cells
    Dalton, William B.
    Shinn, Daniel
    Walsh, Noel
    Christenson, Eric
    Groginski, Taylor
    Kelkar, Dhanashree
    Magugundu, Anil
    Patil, Arun
    Zabransky, Daniel
    Medford, Arielle
    Lee, Justin
    Cole, Alex
    Donaldson, Josh
    DeZern, Amy
    Cravero, Karen
    Chu, David
    Hunter, Natasha
    Pandey, Akhilesh
    Lauring, Josh
    Park, Ben
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Significance of SF3B1 Mutations in Myeloid Neoplasms
    Gajzer, David C.
    Yeung, Cecilia C. S.
    CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 597 - 606
  • [5] SF3B1 mutations in chronic lymphocytic leukemia
    Wan, Youzhong
    Wu, Catherine J.
    BLOOD, 2013, 121 (23) : 4627 - 4634
  • [6] Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42
    Zhao, Bo
    Li, Zhuang
    Qian, Rui
    Liu, Gang
    Fan, Mingyue
    Liang, Zehua
    Hu, Xin
    Wan, Youzhong
    JOURNAL OF BIOCHEMISTRY, 2022, 172 (02): : 117 - 126
  • [7] The Clonal Trajectories of SF3B1 Mutations in Myeloid Neoplasia
    Awada, Hassan
    Kerr, Cassandra M.
    Adema, Vera
    Gurnari, Carmelo
    Pagliuca, Simona
    Rogers, Heesun J.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    Visconte, Valeria
    BLOOD, 2020, 136
  • [8] SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia
    Moison, Celine
    Gracias, Deanne
    Schmitt, Julie
    Girard, Simon
    Spinella, Jean-Francois
    Fortier, Simon
    Boivin, Isabel
    Mendoza-Sanchez, Rodrigo
    Thavonekham, Bounkham
    Macrae, Tara
    Mayotte, Nadine
    Bonneil, Eric
    Wittman, Mark
    Carmichael, James
    Ruel, Rejean
    Thibault, Pierre
    Hebert, Josee
    Marinier, Anne
    Sauvageau, Guy
    SCIENCE ADVANCES, 2024, 10 (12):
  • [9] Molecular Evaluation of SF3B1 Mutations in Cytopenic Patients
    Goyal, B.
    Duncavage, E. J.
    MODERN PATHOLOGY, 2013, 26 : 329A - 330A
  • [10] A Murine Model Harboring Cooperating DNMT3A and SF3B1 Mutations Phenocopies SF3B1 Driven Myelodysplastic Syndrome
    Wallace, Lashanale
    Leal-Cervantes, Ana
    Metidji, Amina
    Myers, Jacquelyn
    Rolle, Chandra
    Tillman, Heather
    Obeng, Esther A.
    BLOOD, 2022, 140 : 5862 - 5863